Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

January 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Gemcitabine and Capecitabine and Avastin

avastin administered concurrently with chemotherapy (gemcitabine + capecitabine) for six cycles followed by single agent avastin to complete one year of treatment. Radiation therapy (if planned) will take place after adjuvant chemotherapy completes.

Trial Locations (3)

87106

University of New Mexico Cancer Center, Albuquerque

02903

Lifespan Hospitals, Providence

02905

Women & Infants' Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Women and Infants Hospital of Rhode Island

OTHER

collaborator

Rhode Island Hospital

OTHER

collaborator

The Miriam Hospital

OTHER

collaborator

Memorial Hospital of Rhode Island

OTHER

collaborator

University of New Mexico Cancer Center

OTHER

lead

Brown University

OTHER